cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.25934/00001400
title: A Randomized Phase III Trial Of Interferon Alfa-2B Or Interferon Alfa-2B Plus Bevacizumab In Patients With Advanced Renal Carcinoma

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.5281/zenodo.1472234
title: Yeast 1-hybrid screens for upstream regulators of A. thaliana AGO1, AGO7, and AGO10: ranked tables of candidate direct upstream TFs

description: This Excel file supplements a paper by Hoyer et al. (2019): https://doi.org/10.1002/pld3.102

The file includes lists of TFs from twelve automated Y1H screens, for user convenience. The first sheet describes the columns. A separate Zenodo record (1345229) includes the raw data and code showing how the data were processed to generate these twelve tables.
DOI: 10.7910/dvn/fiu7zg/4n2ivq
title: 114-5_0005.dcm
DOI: 10.7910/dvn/fiu7zg/8swxey
title: 114-1_0184.dcm
DOI: 10.7910/dvn/fiu7zg/evijpl
title: 114-1_0076.dcm
DOI: 10.7910/dvn/fiu7zg/hopi8z
title: 114-5_0237.dcm
DOI: 10.7910/dvn/fiu7zg/l57xxx
title: 114-1_0239.dcm
DOI: 10.7910/dvn/fiu7zg/mnvrpr
title: 114-1_0043.dcm
DOI: 10.7910/dvn/fiu7zg/q1bkpx
title: 114-5_0078.dcm
DOI: 10.7910/dvn/fiu7zg/usbypg
title: 114-5_0091.dcm
DOI: 10.7910/dvn/fiu7zg/uthu5s
title: 114-1_0042.dcm
DOI: 10.17029/95dfd6c9-1b8c-456e-a208-c19ea8766bde
title: Dataset for Sweden Climate (Abisko): 2011 - 2013

description: Temperature/Relative Humidity observations at 50 sites around Abisko Scientific Research Station (30 min intervals). Please contact author if extensive use of the data for scientific research and publication is envisaged.
DOI: 10.18112/openneuro.ds001574.v1.1.0
title: bass_connections
DOI: 10.25934/00000497
title: Study to Assess Immunogenicity, Reactogenicity and Safety of Primary Vaccination With GSK Biologicals' MenACWY Vaccine (GSK134612) Given as 1 or 2 Doses to Healthy Toddlers 9-12 Months of Age

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00001411
title: An Open-Label, Randomized Study of VELCADE/Melphalan/Prednisone Versus Melphalan/Prednisone in Subjects With Previously Untreated Multiple Myeloma

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.7910/dvn/fiu7zg/1t32wj
title: 114-5_0224.dcm
DOI: 10.7910/dvn/fiu7zg/4kb9ko
title: 114-1_0074.dcm
DOI: 10.7910/dvn/fiu7zg/4ydtrg
title: 114-1_0155.dcm
DOI: 10.7910/dvn/fiu7zg/du6e2y
title: 114-1_0158.dcm
DOI: 10.7910/dvn/fiu7zg/hlcpvk
title: 114-5_0249.dcm
DOI: 10.7910/dvn/fiu7zg/jk2k0h
title: 114-5_0090.dcm
DOI: 10.7910/dvn/fiu7zg/q7juoa
title: 114-5_0099.dcm
DOI: 10.7910/dvn/fiu7zg/vlc9mx
title: 114-1_0244.dcm
DOI: 10.7910/dvn/fiu7zg/xcet0v
title: 114-5_0209.dcm
DOI: 10.7910/dvn/fiu7zg/2wdrzq
title: 114-5_0086.dcm
DOI: 10.7910/dvn/fiu7zg/89hbcq
title: 114-5_0063.dcm
DOI: 10.7910/dvn/fiu7zg/adhqgj
title: 114-1_0236.dcm
DOI: 10.7910/dvn/fiu7zg/byoa63
title: 114-5_0230.dcm
DOI: 10.7910/dvn/fiu7zg/g8zrlo
title: 114-5_0125.dcm
DOI: 10.7910/dvn/fiu7zg/j3ytfx
title: 114-1_0160.dcm
DOI: 10.7910/dvn/fiu7zg/pe1exn
title: 114-1_0150.dcm
DOI: 10.7910/dvn/fiu7zg/ubdhnw
title: 114-1_0015.dcm
DOI: 10.17632/v7bgzx9gmw.1
title: Experimental data set from a benchmark test of delamination growth with varying crack growth rate and crack front shape under quasi-static and fatigue loading

description: This data repository provides the processed data to reproduce the findings presented in the article entitled "A benchmark test for validating 3D simulation methods for delamination growth under quasi-static and fatigue loading" by the same authors. In this work, a comprehensive benchmark case consisting of a double cantilever beam (DCB)-like specimen with partially reinforced arms is presented. The benchmark case is both simple in terms of geometry (easily introduced in a simulation model) and complex in terms of the phenomenology of the crack advance, with varying crack growth rate and front shape. The test configuration, the methodology and the data processing are addressed in the related article. A total number of seven specimens are tested: four under quasi-static and three under fatigue loading conditions. Load-displacement curves and crack front geometries processed from X-ray radiography are provided for all the tests performed. In addition, a complete set of elastic, fracture and fatigue properties for the material are provided in the article. This data set, in conjunction with the associated article, constitutes a comprehensive benchmark test against which existing or future delamination growth models can be evaluated.
DOI: 10.25934/00000522
title: Co-Administration of GSK Biologicals' Meningococcal Vaccine GSK134612 With Infanrix Hexa™, Compared to Individual Administration of Each Vaccine, in Healthy 12- Through 23-Month-Old Children

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00001427
title: A Phase III, Randomized, Double-Blinded, Multi-Center, Study to Assess the Efficacy of Docetaxel (TAXOTERE™) in Combination With ZD6474 (ZACTIMA™) Versus Docetaxel (TAXOTERE™) With Placebo in Subjects With Locally Advanced or Metastatic NSCLC

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00001428
title: A Randomized, Open-Label, Multicenter Study of VELCADE With Rituximab or Rituximab Alone in Subjects With Relapsed or Refractory, Rituximab Naive or Sensitive Follicular B-cell Non-Hodgkin's Lymphoma

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.5281/zenodo.1473039
title: Supplementary Material Table  Anthocoris Minki Pistaciea

description: Tables of life table and growth population parameters of <em>Anthocoris minki pistaciae </em>Wagner (Hemiptera: Anthocoridae) fed on <em>Agonoscena pistaciae</em> Burckhardt and Lauterer (Hemiptera: Psyllidae) at different temperatures
DOI: 10.5281/zenodo.1473040
title: Supplementary Material Table  Anthocoris Minki Pistaciea

description: Tables of life table and growth population parameters of <em>Anthocoris minki pistaciae </em>Wagner (Hemiptera: Anthocoridae) fed on <em>Agonoscena pistaciae</em> Burckhardt and Lauterer (Hemiptera: Psyllidae) at different temperatures
DOI: 10.5281/zenodo.1473454
title: Research-Software/Resosuma-Data: 0.4.1

description: <strong><em>resosuma-data</em></strong> represents activities in the research software sustainability space in the CSV format, where column 1 contains actors in the space, column 2 contains activities, and column 3 contains actees.

resosuma-0.4.1.csv fixes issues #3 and #4.
DOI: 10.7910/dvn/fiu7zg/0fkdbs
title: 114-1_0148.dcm
DOI: 10.7910/dvn/fiu7zg/4qldmi
title: 114-1_0182.dcm
DOI: 10.7910/dvn/fiu7zg/a0jcbi
title: 114-1_0134.dcm
DOI: 10.7910/dvn/fiu7zg/gp2sp3
title: 114-5_0216.dcm
DOI: 10.7910/dvn/fiu7zg/ijxznx
title: 114-1_0228.dcm
DOI: 10.7910/dvn/fiu7zg/rhloyc
title: 114-5_0158.dcm
DOI: 10.7910/dvn/fiu7zg/scvp1w
title: 114-5_0206.dcm
DOI: 10.7910/dvn/fiu7zg/xfnwtu
title: 114-1_0037.dcm
DOI: 10.7910/dvn/fiu7zg/zhdpil
title: 114-1_0061.dcm
DOI: 10.25934/00000527
title: Non-inferiority of GSK Biologicals' Meningococcal Vaccine GSK134612 Versus Mencevax™ in Healthy Subjects Aged 2 Through 10 Years of Age

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00001439
title: A Phase II, Fixed-sequenced, Open- Label, Research Study to Assess Pharmacokinetic Drug Interactions of AEGR-733 on Lipid-lowering Therapies in Healthy Volunteers

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.7910/dvn/fiu7zg/1hrfnd
title: 114-5_0128.dcm
DOI: 10.7910/dvn/fiu7zg/6d4x9w
title: 114-1_0197.dcm
DOI: 10.7910/dvn/fiu7zg/a3xai1
title: 114-1_0225.dcm
DOI: 10.7910/dvn/fiu7zg/aclopx
title: 114-5_0126.dcm
DOI: 10.7910/dvn/fiu7zg/e3xft2
title: 114-1_0035.dcm
DOI: 10.7910/dvn/fiu7zg/i2sfne
title: 114-1_0078.dcm
DOI: 10.7910/dvn/fiu7zg/kokvcb
title: 114-5_0199.dcm
DOI: 10.7910/dvn/fiu7zg/qbm7y4
title: 114-1_0203.dcm
DOI: 10.7910/dvn/fiu7zg/s0lmu9
title: 114-1_0132.dcm
DOI: 10.7910/dvn/fiu7zg/y0oz7i
title: 114-5_0238.dcm
DOI: 10.17632/mm5h9fj4wt.1
title: Data for: Secondary metabolites from lichen as potent inhibitors of advanced glycation end products and vasodilative agents

description: This file contains supplementary material such as raw data for some of the experiments (vasoldilation assay). It further contains structural information and a synthetic protocol of compounds 38-42
DOI: 10.25499/7watxhbiotd5vggnbpcsajfsmg
title: Submitted spectrum for InChIKey YAPQBXQYLJRXSA-UHFFFAOYSA-N
DOI: 10.25499/hutnnm352wnneg3rd3wpx7ujeb
title: Submitted chemical data for InChIKey YAPQBXQYLJRXSA-UHFFFAOYSA-N
DOI: 10.25499/qn77o6mmzomser3tyfd6bfa3cb
title: Submitted chemical data for InChIKey YAPQBXQYLJRXSA-UHFFFAOYSA-N
DOI: 10.25499/u57ou9muejtjewtqx59fmxibxh
title: Submitted chemical data for InChIKey YAPQBXQYLJRXSA-UHFFFAOYSA-N
DOI: 10.25499/vaknuwc6792hexxj449kv3crbf
title: Submitted chemical data for InChIKey YAPQBXQYLJRXSA-UHFFFAOYSA-N
DOI: 10.25934/00001447
title: A Phase 2, Multicenter, Open-Label Study of CNTO 328 (Anti-IL-6 Monoclonal Antibody) in Combination With Mitoxantrone Versus Mitoxantrone in Subjects With Metastatic Hormone-Refractory Prostate Cancer (HRPC)

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00001449
title: A Randomized, Double-Blind, Active Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of the Combination BMS-201038 (AEGR-733) and Ezetimibe vs. Monotherapy in Subjects With Moderate Hypercholesterolemia

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002367
title: Metabolite Radioprofiling and Identification in Plasma, Urine, and Feces in Healthy Volunteers Following Oral Administration of [14C]AEGR-733 (Lomitapide) - Analytical Phase

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002368
title: A PHASE I, OPEN-LABEL, TWO PERIOD SEQUENTIAL STUDY TO DETERMINE THE EFFECT OF LOMITAPIDE, AN MTP INHIBITOR, ON THE PHARMACOKINETICS OF WARFARIN IN HEALTHY SUBJECTS

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002369
title: A Double-Blind, Randomized, Two-Way Crossover Drug-Drug Interaction Study to Assess the Effect of Lomitapide on the Pharmacokinetics of Ortho Cyclen® in Healthy Female Subjects (AEGR-733-015)

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002370
title: An Open-Label Study to Compare the Safety and Pharmacokinetics of Lomitapide in Subjects with Hepatic Impairment and Matched Subjects with Normal Hepatic Function (AEGR-733-017)

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002371
title: An Open-Label Drug-Drug Interaction Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of Lomitapide in Healthy Volunteers

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002372
title: A Phase I Open-label Study to Determine the Effect of High Dose Lomitapide, an MTP Inhibitor, on the Pharmacokinetics of Simvastatin in Healthy Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.7910/dvn/fiu7zg/al9sss
title: 114-1_0214.dcm
DOI: 10.7910/dvn/fiu7zg/eeqpju
title: 114-1_0017.dcm
DOI: 10.7910/dvn/fiu7zg/hfxrkz
title: 114-5_0119.dcm
DOI: 10.7910/dvn/fiu7zg/jvz1ju
title: 114-5_0228.dcm
DOI: 10.7910/dvn/fiu7zg/oniyzz
title: 114-1_0210.dcm
DOI: 10.7910/dvn/fiu7zg/opallk
title: 114-5_0152.dcm
DOI: 10.7910/dvn/fiu7zg/otduvq
title: 114-1_0249.dcm
DOI: 10.7910/dvn/fiu7zg/vnuxvj
title: 114-5_0210.dcm
DOI: 10.25499/omfgax7ukrxdvwpdw9kaq72atb
title: Submitted chemical data for InChIKey YAPQBXQYLJRXSA-UHFFFAOYSA-N
DOI: 10.25934/00002373
title: Ascending Single-Dose Safety, Tolerance, Pharmacokinetic, and Pharmacodynamic Study of BMS-201038 in Healthy Volunteers

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002374
title: Ascending Multiple-dose Safety, Tolerance, Pharmacokinetic, and Pharmacodynamic Study of BMS-201038 in Healthy Volunteers

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002375
title: Single-Dose Pharmacokinetics, Pharmacodynamics, and Safety of Intraveous BMS-201038 in Healthy Volunteers

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002377
title: Disposition of BMS-201038 in Healthy Subjects After Oral Administration of [14c]BMS-201038

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002378
title: THE EFFECTS OF CHRONIC DOSING OF BMS-201038 ON HEPATIC FAT ACCUMULATION AND REVERSIBILITY AS ASSESSED BY NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY (NMRS)

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002379
title: Multiple-Dose Safety, Tolerance, Pharmacokinetic and Pharmacodynamic Study of BMS-201038 in Healthy Female Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.7910/dvn/fiu7zg/2aayzf
title: 114-1_0105.dcm
DOI: 10.7910/dvn/fiu7zg/4wv4qc
title: 114-1_0039.dcm
DOI: 10.7910/dvn/fiu7zg/afsumi
title: 114-1_0152.dcm
DOI: 10.7910/dvn/fiu7zg/icn5py
title: 114-1_0101.dcm
DOI: 10.7910/dvn/fiu7zg/j7pptj
title: 114-5_0197.dcm
DOI: 10.7910/dvn/fiu7zg/snwhkq
title: 114-5_0130.dcm
DOI: 10.7910/dvn/fiu7zg/svywxc
title: 114-5_0111.dcm
DOI: 10.7910/dvn/fiu7zg/taucr4
title: 114-1_0248.dcm
DOI: 10.7910/dvn/fiu7zg/vubbrw
title: 114-5_0236.dcm
DOI: 10.7910/dvn/fiu7zg/yoea8j
title: 114-5_0184.dcm
DOI: 10.25934/00001458
title: A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Safety and Efficacy of the Combination of AEGR-733 (Formerly BMS201038) and Atorvastatin 20 mg vs. Monotherapy in Subjects With Moderate Hypercholesterolemia

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.5287/bodleian:zo7qyxe69
title: A magnetic guide to purify radical beams dataset
DOI: 10.7910/dvn/fiu7zg/0bzere
title: 114-1_0097.dcm
DOI: 10.7910/dvn/fiu7zg/7yfuu9
title: 114-1_0001.dcm
DOI: 10.7910/dvn/fiu7zg/adx6ek
title: 114-1_0142.dcm